DHR Investissement

DHR Investissement is a French holding company and investment vehicle for the Dassault family, operating as part of the Groupe Industriel Marcel Dassault (GIMD). The firm is a key player in the healthcare and life sciences ecosystem, primarily through its significant ownership stake in Dassault Systèmes, a global leader in virtual twin technology and software solutions for the life sciences industry. DHR Investissement also manages a portfolio of direct investments in innovative biotechnology and medical technology companies, focusing on areas such as gene therapy, cardiovascular devices, and digital health. Notable portfolio companies include GenSight Biologics, which develops gene therapies for retinal diseases, and CorWave, a developer of innovative heart pumps. The firm leverages the technological and industrial expertise of the Dassault Group to support advancements in precision medicine and healthcare digitalization.